Regulatory Approval in China
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- Offer Booklet for Renounceable Rights Issue
- Technegas COPD Trial Update
- Update on Cyclotron Facility
- Technegas May Facilitate Earlier Diagnosis of COPD
- Technegas Clinical Trial - First Patient Enrolled
Later from Cyclopharm
- Cyclopharm Files Claim Against ANSTO
- Cyclopharm to Proceed Independently with FDA Trials
- Trading Update & Record Technegas Order Received from China
- CYC Signs Agreement with the Canadian Association of Nuc Med
- Appendix 4D and Half Year Accounts
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm